Prostanoids as Regulators of Innate and Adaptive Immunity

被引:87
作者
Hirata, Takako [1 ]
Narumiya, Shuh [1 ]
机构
[1] Kyoto Univ, Grad Sch Med, Dept Pharmacol, Kyoto, Japan
来源
ADVANCES IN IMMUNOLOGY, VOL 116 | 2012年 / 116卷
关键词
MULTIPLE SIGNALING PATHWAYS; MOUSE PROSTACYCLIN RECEPTOR; PROSTAGLANDIN D-2 RECEPTOR; DENDRITIC CELL-FUNCTION; MICE LACKING; ALLERGIC INFLAMMATION; THROMBOXANE A(2); FUNCTIONAL EXPRESSION; CYTOKINE PRODUCTION; INTERNATIONAL UNION;
D O I
10.1016/B978-0-12-394300-2.00005-3
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Potent, oxygenated lipid molecules called prostanoids regulate a wide variety of physiological responses and pathological processes. Prostanoids are produced by various cell types and act on target cells through specific G protein-coupled receptors. Although prostanoids have historically been considered acute inflammation mediators, studies using specific receptor knockout mice indicate that prostanoids, in fact, regulate various aspects of both innate and adaptive immunity. Each prostanoid, depending on which receptor it acts on, exerts specific effects on immune cells such as macrophages, dendritic cells, and T and B lymphocytes, often in concert with microbial ligands and cytokines, to affect the strength, quality, and duration of immune responses. Prostanoids are also relevant to immunopathology, from inflammation to autoimmunity and cancer. Here, we review the role of prostanoids in regulating immunity, their involvement in immunopathology, and areas of insight that may lead to new therapeutic opportunities.
引用
收藏
页码:143 / 174
页数:32
相关论文
共 144 条
[1]   Molecular cloning, chromosome mapping and characterization of the mouse CRTH2 gene, a putative member of the leukocyte chemoattractant receptor family [J].
Abe, H ;
Takeshita, T ;
Nagata, K ;
Arita, T ;
Endo, Y ;
Fujita, T ;
Takayama, H ;
Kubo, M ;
Sugamura, K .
GENE, 1999, 227 (01) :71-77
[2]  
ABRAMOVITZ M, 1994, J BIOL CHEM, V269, P2632
[3]   Prostaglandin analog treatment of glaucoma and ocular hypertension [J].
Alexander, CL ;
Miller, SJ ;
Abel, SR .
ANNALS OF PHARMACOTHERAPY, 2002, 36 (03) :504-511
[4]   Role of the parasite-derived prostaglandin D2 in the inhibition of epidermal Langerhans cell migration during schistosomiasis infection [J].
Angeli, V ;
Faveeuw, C ;
Roye, O ;
Fontaine, J ;
Teissier, E ;
Capron, A ;
Wolowczuk, I ;
Capron, M ;
Trottein, F .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 193 (10) :1135-1147
[5]   Activation of the D prostanoid receptor 1 regulates immune and skin allergic responses [J].
Angeli, W ;
Staumont, D ;
Charbonnier, AS ;
Hammad, H ;
Gosset, P ;
Pichavant, M ;
Lambrecht, BN ;
Capron, M ;
Dombrowicz, D ;
Trottein, F .
JOURNAL OF IMMUNOLOGY, 2004, 172 (06) :3822-3829
[6]  
BASTIEN L, 1994, J BIOL CHEM, V269, P11873
[7]   MOLECULAR-CLONING AND CHARACTERIZATION OF THE HUMAN PROSTANOID DP RECEPTOR [J].
BOIE, Y ;
SAWYER, N ;
SLIPETZ, DM ;
METTERS, KM ;
ABRAMOVITZ, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (32) :18910-18916
[8]  
BOIE Y, 1994, J BIOL CHEM, V269, P12173
[9]   Prostaglandin E2 regulates Th17 cell differentiation and function through cyclic AMP and EP2/EP4 receptor signaling [J].
Boniface, Katia ;
Bak-Jensen, Kristian S. ;
Li, Ying ;
Blumenschein, Wendy M. ;
McGeachy, Mandy J. ;
McClanahan, Terrill K. ;
McKenzie, Brent S. ;
Kastelein, Robert A. ;
Cua, Daniel J. ;
Malefyt, Rene de Waal .
JOURNAL OF EXPERIMENTAL MEDICINE, 2009, 206 (03) :535-548
[10]   Prostanoid receptors: Subtypes and signaling [J].
Breyer, RM ;
Bagdassarian, CK ;
Myers, SA ;
Breyer, MD .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2001, 41 :661-690